Michel Favre

Title: Michel Favre: Innovator in Human Papillomavirus Research

Introduction

Michel Favre is a prominent inventor based in Paris, France. He has made significant contributions to the field of immunology, particularly in the study of human papillomavirus (HPV). With a total of 10 patents, Favre's work has advanced the understanding and detection of HPV, which is crucial for public health.

Latest Patents

Favre's latest patents include innovative immunogenic compositions of human papillomavirus. One notable patent involves a purified human papillomavirus gene selected from a specific group, including E1, E6-E7, L1, and L2. This invention focuses on various HPV types, such as HPV-2d, HPV-10b, and HPV-31, among others. The polypeptides encoded by these genes can be utilized in immunogenic compositions, enhancing the potential for effective vaccines and diagnostic tools. Another significant patent addresses the methods of detecting HPV using probes derived from these papillomaviruses, further contributing to the field of HPV research.

Career Highlights

Throughout his career, Michel Favre has worked with esteemed institutions such as the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in developing methods for HPV detection and understanding its implications in human health.

Collaborations

Favre has collaborated with notable colleagues, including Gerard Orth and Dina Kremsdorf. These partnerships have fostered a collaborative environment that has led to significant advancements in HPV research.

Conclusion

Michel Favre's contributions to the field of immunology and HPV research are invaluable. His innovative patents and collaborations have paved the way for advancements in detection and treatment, making a lasting impact on public health.